Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Rutkowski

Showing results (121-130 of 253) with videos related to

Pageof 26
Sort By:
Neuro-Oncology|June 4, 2011
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histologyAndré O von Bueren, Katja von Hoff, Torsten Pietsch, et al.
BMC Cancer|February 18, 2011
c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patientsAndré O von Bueren, Christoph Oehler, Tarek Shalaby, et al.
Pediatric Blood & Cancer|April 30, 2013
Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working groupKatherine E Warren, Tina Y Poussaint, Gilbert Vezina, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapyNicolas U Gerber, Katja von Hoff, Anika Resch, et al.
Neuro-Oncology|December 11, 2012
Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapyCarsten Friedrich, André O von Bueren, Katja von Hoff, et al.
The American Journal of Surgical Pathology|August 30, 2008
Hypothalamic papillary tumor in a patient with tuberous sclerosisMartin Hasselblatt, Jaroslaw Jozwiak, Karin Mayer, et al.
Journal of Neuro-Oncology|June 23, 2009
Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 studyBrigitte Wrede, Martin Hasselblatt, Ove Peters, et al.
Journal of Neuro-Oncology|April 7, 2006
Treatment options in childhood pontine gliomasSabine Wagner, Monika Warmuth-Metz, Angela Emser, et al.
Acta Neuropathologica|January 24, 2024
Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphologySwenja Gödicke, Catena Kresbach, Max Ehlert, et al.
Pediatric Blood & Cancer|July 29, 2011
Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT databaseKatja von Hoff, Bernward Hinkes, Elke Dannenmann-Stern, et al.
Pageof 26

Showing results (121-130 of 253) with videos related to

Sort By:
Pageof 26
Neuro-Oncology|June 4, 2011
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histologyAndré O von Bueren, Katja von Hoff, Torsten Pietsch, et al.
BMC Cancer|February 18, 2011
c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patientsAndré O von Bueren, Christoph Oehler, Tarek Shalaby, et al.
Pediatric Blood & Cancer|April 30, 2013
Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working groupKatherine E Warren, Tina Y Poussaint, Gilbert Vezina, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapyNicolas U Gerber, Katja von Hoff, Anika Resch, et al.
Neuro-Oncology|December 11, 2012
Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapyCarsten Friedrich, André O von Bueren, Katja von Hoff, et al.
The American Journal of Surgical Pathology|August 30, 2008
Hypothalamic papillary tumor in a patient with tuberous sclerosisMartin Hasselblatt, Jaroslaw Jozwiak, Karin Mayer, et al.
Journal of Neuro-Oncology|June 23, 2009
Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 studyBrigitte Wrede, Martin Hasselblatt, Ove Peters, et al.
Journal of Neuro-Oncology|April 7, 2006
Treatment options in childhood pontine gliomasSabine Wagner, Monika Warmuth-Metz, Angela Emser, et al.
Acta Neuropathologica|January 24, 2024
Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphologySwenja Gödicke, Catena Kresbach, Max Ehlert, et al.
Pediatric Blood & Cancer|July 29, 2011
Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT databaseKatja von Hoff, Bernward Hinkes, Elke Dannenmann-Stern, et al.
Pageof 26